Skip to main content

Table 4 Brazil SUS Incorporations and PCDTs – National Committee for Technology Incorporation (CONITEC) Recommendations 2016–2019

From: A civil society view of rare disease public policy in six Latin American countries

YearTreatmentRare DiseaseDecisionDate
2016 [32]
TobramycinCystic FibrosisIncorporate10/27/2016
GolimumabPsoriatic ArthritisIncorporate4/12/2016
PancrelipaseCystic FibrosisExclude1/18/2016
2017 [33]
IdursulfaseMPS IIIncorporate12/20/2017
SomatropinTurner Syndrome and HypopituitarismIncorporate11/3/2017
LaronidaseMPS IIncorporate9/4/2017
PCDTCystic Fibrosis (Pancreatic Insufficiency)Approve9/4/2017
PCDTCystic Fibrosis (Pulmonary)Approve9/4/2017
AlfataligliceraseGaucher DiseaseIncrease use7/12/2017
PCDTPsoriatic ArthritisApprove7/19/2017
PCDTGaucher DiseaseApprove6/27/2017
2018 [34]
PirfenidoneIdiopathic Pulmonary FibrosisNot Incorporate12/26/2018
NintedanibIdiopathic Pulmonary FibrosisNot Incorporate12/26/2018
Zoledronic AcidPaget’s DiseaseIncorporate12/21/2018
GalsulfaseMPS VIIncorporate12/20/2018
Elosulfase AlfaMPS IVaIncorporate12/20/2018
SapropterinPhenylketonuriaIncorporate12/17/2018
EculizumabParoxistic Nocturnal HemoglobinuriaIncorporate12/17/2018
Agalsidase (Alfa and Beta)Fabry’s DiseaseNot Incorporate12/17/2018
Eltrombopag OlamineIdiopathic Thrombocytopenic PurpuraIncorporate12/12/2018
RomiplostimIdiopathic Thrombocytopenic PurpuraNot Incorporate12/12/2018
PCDTAutoimmne Hemolytic AnemiaApprove12/10/2018
PCDTPsoriatic ArthritisApprove11/5/2018
PCDTFamilial Amyloid PolyneuropathyApprove10/10/2018
PCDTMPS IIApprove5/25/2018
PCDTTurner SyndromeApprove5/24/2018
PCDTAutoimmune HepatitisApprove5/24/2018
PCDTBiotinidase DeficiencyApprove5/24/2018
PCDTMPS IApprove4/18/2018
PCDTWilson DiseaseApprove4/9/2018
PCDTSickle Cell DiseaseApprove2/22/2018
CertolizumabPsoriatic ArthritisNot Incorporate1/25/2018
UstekinumabPsoriatic ArthritisNot Incorporate1/25/2018
TafamidisFamilial Amyloid PolyneuropathyIncorporate1/18/2018
2019 (Up to 4/1/19) [35]
Eftrenonacog AlfaHemophilia BNot Incorporate2/22/2019
Efmoroctocog AlfaHemophilia ANot Incorporate2/22/2019
SecukinumabPsoriatic ArthritisIncorporate1/21/2019
PCDTAcromegalyApprove1/14/2019